TrophAmine Articles
AstraZeneca pays Cubist $10.25M up front for Asian right to Cubicin
18 December 2006
BioAlliance gets AFSSAPS ok for Ph II/III liver cancer trial
18 December 2006
PXD101 shows promise in Phase II MM trial
18 December 2006
QLT
11 December 2006
Neurobiological to step up Viprinex production
11 December 2006
FDA approves Abraxis' ANDA for generic combo antibiotic
4 December 2006
Natura Thera launches nutrient for stem cells
4 December 2006
US FDA clears Teva's generic of GSK's Zofran
4 December 2006
Macugen use safe for three years
27 November 2006
Pooled analysis of Xcytrin in lung cancer brain metastases
27 November 2006
ThromboGenics's MVI III trial cleared by FDA
20 November 2006
Pozen submits full Trexima response to FDA
20 November 2006
Genta's Genasense shows preclinical efficacy
20 November 2006
Cytogen's 3rd-qtr 2006 net loss improves 24%
13 November 2006
Sanofi-Aventis gets EMEA ok for Taxotere in SCHN
13 November 2006
Mixed results for Novo Nordisk in 3rd-qtr 2006
6 November 2006
MacuSight initiates 30-patient sirolimus trial
6 November 2006
Shire launches Ph IIIb Dynepo trial
6 November 2006
Good efficacy in early data on MVA-BN-HER2
6 November 2006
IDM submits Junovan NDA to FDA
6 November 2006
Pfizer's celecoxib to become Japan's first COX-2 inhibitor
30 October 2006
Takeda's Takepron for injection OKed in Japan
30 October 2006
Lilly's Almita enters Ph III trial for SCLC
30 October 2006
US scientists identify new paradigm in tennis elbow repair
30 October 2006
China's SFDA revokes 15 GMP certificates
30 October 2006
Serono's 3rd-qtr 2006 sales rise 8.4% on Rebif
30 October 2006
Akzo's income hits 313M euro for 3rd-qtr
23 October 2006
TorreyPines' tezampanel enters Ph IIb migraine trial
23 October 2006
ImmuPharma's lupus drug impresses in Ph II study
23 October 2006
Good early data for Hollis-Eden's Neumune
23 October 2006
China' SFDA clears China Pharma's granisetron
16 October 2006
Humira superior to MTX in psoriasis study
16 October 2006
Novartis' Lucentis improves visual acuity in wet AMD, two pivotal Ph III studies find
16 October 2006
GSK's Arixtra gets fast tracked by US FDA
16 October 2006
IDMC recommends Ph III Yondelis trial continues
16 October 2006
Stock Commentary - Tokyo week to Oct 2, 2006
9 October 2006
Pakistan Supreme Court enters fake drug fray
9 October 2006
PowderMed initiates Ph I trial of DNA flu vacc
9 October 2006
Meridian's Duodote gains FDA clearance
9 October 2006
Eli Lilly PAP approved, patients hit by Part D loophole
9 October 2006
Strong Ph II data for Org 36286
2 October 2006
Trasylol endorsed by FDA in CABG surgery
2 October 2006
Amgen's Denosumab MAb effective in trial
2 October 2006
EASD panels recommend insulin acceptance, and highlight shortfalls in DPNP therapy
25 September 2006
Germany spends 3.28B euros on wet AMD
25 September 2006
Serono to evaluate Syntronix' SynFusion
25 September 2006
Apitope elucidates IL-10 role in AI diseases
25 September 2006
EuroPharma and New Chapter agree dist deal
25 September 2006
MS patients on Teva's Copaxone miss less working days
18 September 2006
Vernalis' losses for 1st-half 2006 down slightly
18 September 2006
13 new drugs added to Japan's NHI list
18 September 2006
Meabco's BP-C1 enters Ph IIb breast cancer trial
18 September 2006
Dynavax secures $30M equity injection
11 September 2006
ACE BioSci's Campylobacter vacc enters Ph I trial
4 September 2006
FDA's RHDAC votes in favor of Adeza's Gestiva
4 September 2006
Neurobiologicals selects sites for Ph III Viprinex trials
4 September 2006
Devgen sees good data in trials of oral TNF inhibitors
28 August 2006
FDA delays Genasense trial clearance
28 August 2006
Schering AG's Betaferon cuts risk of clinical MS
28 August 2006
Strong Ph III data on Cubist's Cubicin
28 August 2006
Medicure acquires US rights to Aggrastat
14 August 2006
China approves new drug regulations
14 August 2006
Pfizer's Macugen cleared in Scotland
14 August 2006
EMEA orphan status for MGI's Dacogen
7 August 2006
Serono's net income up 8% in 2nd-qtr
31 July 2006
Amylin's 2nd-qtr loss deepens to $46.4M
31 July 2006
Ipsen to move into USA via Tercica
31 July 2006
OVATION Pharma debuts NeoProfen
31 July 2006
Akzo Nobel's 2nd-qtr sales hit 3.57B euros
31 July 2006
MGI Pharma moves into loss for 2nd-qtr
24 July 2006
Roche pays Memory $2.3M AD milestone
24 July 2006
Gilead to donate $1.1M a year to Czech IOCB
24 July 2006
Q-Med launches Cosmofer in Sweden
17 July 2006
Teva and Eisai halt US collaboration on rasagiline
17 July 2006
Dragon sells Chinese formulation business
17 July 2006
Nobilon enters RSV vacc accord with NVI
10 July 2006
EMEA validates Insmed's Iplex MA
10 July 2006
Tysabri gets EC approval for relapsing MS
10 July 2006
Abraxis completes purchase of AstraZeneca brands
3 July 2006
S&N in strategic alliance with Q-MED
3 July 2006
Biosignal gets $1.2M from Japan's Restoration
3 July 2006
Supergen sells US Nipent rights to Mayne
3 July 2006
Japan stock market week to June 19, 2006
26 June 2006
Menopur more effective than rFSH in IVF
26 June 2006
Good 2 yr sugar control on Amylin/Lilly's Byetta
19 June 2006
Insmed updates on IPLEX launch
13 June 2006
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
